A Sub Study of the Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)
Public ClinicalTrials.gov record NCT05320146. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b, Open-Label Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Adult Patients With Presumed Nonalcoholic Steatohepatitis (NASH)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This optional sub study is a part of the phase 1b, Open-Label Study is to assess the safety, efficacy of miricorilant in patients with presumed Nonalcoholic Steatohepatitis (NASH)
Study identification
- NCT ID
- NCT05320146
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 22 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 3, 2022
- Primary completion
- Jul 17, 2023
- Completion
- Jul 17, 2023
- Last update posted
- Aug 18, 2024
2022 – 2023
United States locations
- U.S. sites
- 9
- U.S. states
- 4
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 207 | Chandler | Arizona | 85224 | — |
| Site 209 | Tucson | Arizona | 85712 | — |
| Site 214 | Panorama City | California | 91402 | — |
| Site 233 | Santa Ana | California | 92704 | — |
| Site 211 | Austin | Texas | 78757 | — |
| Site 213 | Edinburg | Texas | 78539 | — |
| 305 | Houston | Texas | 77079 | — |
| Site 212 | San Antonio | Texas | 78229 | — |
| 226 | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Nonalcoholic Steatohepatitis (NASH) trials
Other public records listing Nonalcoholic Steatohepatitis (NASH). Sorted by last update posted; newest first. Not a recommendation.
- NCT07553663: Evaluating the Pharmacokinetics and Safety of Miricorilant Recruiting
- NCT06108219: A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH) Active, not recruiting
- NCT06947304: Evaluation of Miricorilant on Liver Fat in Patients With MASLD Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05320146, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 18, 2024 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05320146 live on ClinicalTrials.gov.